Simulations Plus (NASDAQ:SLP) Sets New 52-Week Low – Here’s What Happened

Simulations Plus, Inc. (NASDAQ:SLP)’s stock price hit a new 52-week low during trading on Friday . The stock traded as low as $24.00 and last traded at $24.96, with a volume of 95166 shares trading hands. The stock had previously closed at $24.68.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on SLP shares. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. KeyCorp lifted their target price on shares of Simulations Plus from $35.00 to $37.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, one has given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $49.40.

Simulations Plus Trading Up 4.6 %

The stock’s fifty day moving average price is $31.35 and its two-hundred day moving average price is $30.98. The stock has a market capitalization of $518.67 million, a P/E ratio of 64.52 and a beta of 0.89.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the transaction, the director now owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 19.40% of the company’s stock.

Hedge Funds Weigh In On Simulations Plus

Hedge funds have recently bought and sold shares of the company. Barclays PLC boosted its stake in Simulations Plus by 390.6% in the 3rd quarter. Barclays PLC now owns 28,473 shares of the technology company’s stock worth $911,000 after purchasing an additional 22,669 shares in the last quarter. Proficio Capital Partners LLC bought a new position in Simulations Plus in the 4th quarter worth about $719,000. Geode Capital Management LLC boosted its stake in Simulations Plus by 4.4% in the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after purchasing an additional 18,924 shares in the last quarter. State Street Corp boosted its stake in Simulations Plus by 4.7% in the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company’s stock worth $20,503,000 after purchasing an additional 28,953 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in Simulations Plus by 106.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company’s stock worth $1,517,000 after purchasing an additional 24,371 shares in the last quarter. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.